These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16036531)

  • 21. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population.
    Delate T; Mager DE; Sheth J; Motheral BR
    Am J Manag Care; 2005 Jan; 11(1):29-36. PubMed ID: 15697098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms.
    Howden CW; Blume SW; de Lissovoy G
    Am J Manag Care; 2007 Jan; 13(1):37-44. PubMed ID: 17227202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors of peptic ulcer in 4943 inpatients.
    Talamini G; Tommasi M; Amadei V; Pajusco B; Fratucello A; Lechi A; Scroccaro G; Vantini I
    J Clin Gastroenterol; 2008 Apr; 42(4):373-80. PubMed ID: 18277902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding.
    Tsoi KK; Lau JY; Sung JJ
    Gastrointest Endosc; 2008 Jun; 67(7):1056-63. PubMed ID: 18407271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
    Lanas A; García-Rodríguez LA; Polo-Tomás M; Ponce M; Alonso-Abreu I; Perez-Aisa MA; Perez-Gisbert J; Bujanda L; Castro M; Muñoz M; Rodrigo L; Calvet X; Del-Pino D; Garcia S
    Am J Gastroenterol; 2009 Jul; 104(7):1633-41. PubMed ID: 19574968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronotherapy approaches in the treatment of gastroduodenal ulcer].
    Maev IV; V'iuchnova ES; Dicheva DT; Lebedeva EG
    Klin Med (Mosk); 2002; 80(3):46-9. PubMed ID: 11980160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
    Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
    Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal telangiectasia: a study by EGD, colonoscopy, and capsule endoscopy in 75 patients.
    Polese L; D'Incà R; Angriman I; Scarpa M; Pagano D; Ruffolo C; Lamboglia F; Sturniolo GC; D'Amico DF; Norberto L
    Endoscopy; 2008 Jan; 40(1):23-9. PubMed ID: 18058652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up.
    Leung WK; Wu JC; Chan FK; Fung SS; Wong VW; Hui AJ; Hung LC; Sung JJ
    Am J Gastroenterol; 2007 Jul; 102(7):1483-8. PubMed ID: 17593161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.
    Wong GL; Wong VW; Chan Y; Ching JY; Au K; Hui AJ; Lai LH; Chow DK; Siu DK; Lui YN; Wu JC; To KF; Hung LC; Chan HL; Sung JJ; Chan FK
    Gastroenterology; 2009 Aug; 137(2):525-31. PubMed ID: 19445937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.
    van Soest EM; Sturkenboom MC; Dieleman JP; Verhamme KM; Siersema PD; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Jul; 26(2):265-75. PubMed ID: 17593072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brand versus generic alendronate: gastrointestinal effects measured by resource utilization.
    Halkin H; Dushenat M; Silverman B; Shalev V; Loebstein R; Lomnicky Y; Friedman N
    Ann Pharmacother; 2007 Jan; 41(1):29-34. PubMed ID: 17190847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
    Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
    Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
    Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of antisecretory drugs among consumers of non-steroidal anti-inflammatory drugs in the general population.
    Rey E; Elola-Olaso CM; Rodríguez-Artalejo F; Locke GR; Diaz-Rubio M
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1585-92. PubMed ID: 17206946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.